DE2723451A1 - Polyribonucleotide, verfahren zu ihrer herstellung und ihre verwendung als oder in arzneimitteln - Google Patents

Polyribonucleotide, verfahren zu ihrer herstellung und ihre verwendung als oder in arzneimitteln

Info

Publication number
DE2723451A1
DE2723451A1 DE19772723451 DE2723451A DE2723451A1 DE 2723451 A1 DE2723451 A1 DE 2723451A1 DE 19772723451 DE19772723451 DE 19772723451 DE 2723451 A DE2723451 A DE 2723451A DE 2723451 A1 DE2723451 A1 DE 2723451A1
Authority
DE
Germany
Prior art keywords
arn
polyribonucleotides
fragments
ribonuclease
degradation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19772723451
Other languages
German (de)
English (en)
Other versions
DE2723451C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Mirko Beljanski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE2723451A1 publication Critical patent/DE2723451A1/de
Application granted granted Critical
Publication of DE2723451C2 publication Critical patent/DE2723451C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19772723451 1976-06-03 1977-05-24 Polyribonucleotide, verfahren zu ihrer herstellung und ihre verwendung als oder in arzneimitteln Granted DE2723451A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7616875A FR2353293A1 (fr) 1976-06-03 1976-06-03 Polyribonucleotides ayant une activite dans la genese des leucocytes et des plaquettes sanguines

Publications (2)

Publication Number Publication Date
DE2723451A1 true DE2723451A1 (de) 1977-12-22
DE2723451C2 DE2723451C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-09-07

Family

ID=9173980

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772723451 Granted DE2723451A1 (de) 1976-06-03 1977-05-24 Polyribonucleotide, verfahren zu ihrer herstellung und ihre verwendung als oder in arzneimitteln

Country Status (14)

Country Link
US (2) US4190649A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JPS52148613A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE855309A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1093000A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH620691A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2723451A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK169766B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2353293A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1546322A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE45285B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU77460A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7705658A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO145540C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE441679B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4558010A (en) * 1980-04-03 1985-12-10 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator and method of making plasminogen activator protein therefrom
JPS5927833A (ja) * 1982-08-06 1984-02-14 Advance Res & Dev Co Ltd コレステロール乃至トリグリセリド低下剤
JPS59219235A (ja) * 1983-05-30 1984-12-10 Mitsui Toatsu Chem Inc 消化性潰瘍用剤
JPS61151128A (ja) * 1984-12-24 1986-07-09 Advance Res & Dev Co Ltd コレステロ−ル低下活性ｒｎａ画分
JPS625991A (ja) * 1985-07-03 1987-01-12 Advance Res & Dev Co Ltd コレステロ−ル乃至トリグリセリド低下活性ｒｎａ画分
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system
SU1575359A1 (ru) * 1988-06-14 1991-05-15 Институт Морфологии Человека Амн Ссср Способ получени рибонуклеотидов
CN101611047A (zh) * 2006-10-27 2009-12-23 分子国际研究公司 基于施用小rna片段的治疗性治疗
RU2620069C2 (ru) * 2014-06-26 2017-05-22 Аоварт Гмбх Вещество и способ модуляции пролиферации и дифференцировки регуляторных, стволовых и других соматических клеток

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2325072A1 (de) * 1972-05-19 1973-11-29 Georges Tixier Arzneimittel auf der basis von lysinderivaten zur bekaempfung der leukopenie

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3457254A (en) * 1965-10-09 1969-07-22 Asahi Chemical Ind Process for preparing nucleosides
BR6801650D0 (pt) * 1968-08-20 1973-03-07 R Maes Processo para preparacao de complexos geradores de interferon
US3980776A (en) * 1969-05-26 1976-09-14 Nakao Ishida Composition containing double stranded RNA from basidiomycetes and method of use
BE757653A (fr) * 1969-10-21 1971-04-16 Ugine Kuhlmann Nouveaux medicaments derives d'acides nucleiques et procedes pour leur preparation
GB1356263A (en) * 1971-01-14 1974-06-12 Beecham Group Ltd Modified double-stranded rna
BE790953A (fr) * 1971-11-05 1973-05-03 Beecham Group Ltd Matiere biologiquement active
FR2292481A1 (fr) * 1974-11-26 1976-06-25 Anvar Nouveaux polynucleotides, leurs procedes de preparation, et medicaments a base de ces produits

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2325072A1 (de) * 1972-05-19 1973-11-29 Georges Tixier Arzneimittel auf der basis von lysinderivaten zur bekaempfung der leukopenie

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BELJANSKI, Mirko et al.: ARN-Fragments, amorceurs nEcessaires A la rEplication in vitro des ADN. In: C.R. Acad. Sci. Paris, Z. 280, Serie D, 1975, S.363-6, ibid. S. 1189-92 *
BELJANSKI, Mirko et al.: ARN-Fragments, amorceurs nécessaires á la réplication in vitro des ADN. In: C.R. Acad. Sci. Paris, Z. 280, Serie D, 1975, S.363-6, ibid. S. 1189-92
BOCK, R.M.: Alkaline Hydrolysis of RNA. In: Methods in Enzymology, Vol. 12, Pt. A., 1967, S. 224-239 *
Handbook of Biochemistry and Molecular Biology, 3rd Ed., 1975, S. 402-4 *

Also Published As

Publication number Publication date
NO145540C (no) 1982-04-14
CA1093000A (en) 1981-01-06
LU77460A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-01-26
JPS52148613A (en) 1977-12-10
IE45285B1 (en) 1982-07-28
DE2723451C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-09-07
NO771884L (no) 1977-12-06
NL7705658A (nl) 1977-12-06
JPS6326088B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-05-27
DK169766B1 (da) 1995-02-20
NO145540B (no) 1982-01-04
US4190649A (en) 1980-02-26
SE7706425L (sv) 1977-12-04
SE441679B (sv) 1985-10-28
FR2353293B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-01-12
BE855309A (fr) 1977-12-02
CH620691A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-12-15
US4335239A (en) 1982-06-15
GB1546322A (en) 1979-05-23
DK243877A (da) 1977-12-04
IE45285L (en) 1977-12-03
JPS63119495A (ja) 1988-05-24
FR2353293A1 (fr) 1977-12-30
JPH027599B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-02-19

Similar Documents

Publication Publication Date Title
DE2954387C2 (de) Die tumorspezifische Immunität vergrößernder Bakterienzellenextrakt und Verfahren zu seiner Herstellung
DE3855525T2 (de) Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS.
DE69019640T2 (de) Verfahren zur herstellung von beta-1,3-glucan in algen.
DE60103066T2 (de) Chlorella zubereitungen mit immunmodulatorischen eigenschaften
DE3407823C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE69621776T2 (de) Antitumorpräparate, die eine lipoteichonsäure aus streptococcus enthalten
EP0721457B1 (de) Gegen Papillomaviren wirksame 2',5'-OLIGOADENYLAT-2',3'-CYCLOPHOSPHATE und 2',5'-OLIGOADENYLATE
CH650404A5 (de) Zedrachborken-extrakt mit antineoplastischer wirksamkeit und verfahren zu dessen herstellung.
DE2735411A1 (de) Verfahren zur herstellung von acellulaeren vaccinen und nach diesem verfahren gewonnene vaccine
DE2723451C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE3109335C2 (de) Ebelacton A und B, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
DE2024586C3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE3304468A1 (de) Mikroorganismenzellen die s-adenosylmethionin enthalten verfahren zu deren herstellung
DD215580A5 (de) Hypocholesterolaemisch aktives protein
DE2930604A1 (de) Doppelstrangige ribonucleinsaeure, verfahren zu ihrer herstellung und diese enthaltende interferon-induktoren
DE2048375A1 (de) Wirksammachung von Antibiotika
DE2518474A1 (de) Mitogenes mittel, verfahren zu seiner herstellung und diese mittel enthaltende arzneimittel und biologische reagenzien
DE2048848A1 (de) Verfahren zur Herstellung eines Korn plexes aus RNS und Polysacchand, Verfahren zur Gewinnung der Polysacchand Komponente und ihre Verwendung zur Herstellung von Arzneimitteln
DE2911353A1 (de) 3-o-( beta -d-glucoronpyranosyl)- sojasapogenol b, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
DE69918953T2 (de) Zusammensetzung von oligosacchariden zur regulierung von apoptose
DE3543267A1 (de) Acylglykan-extrakte von klebsiella, deren gewinnungsverfahren, deren verwendung als arzneimittel und die sie enthaltenden zusammensetzungen
CH639133A5 (de) Verfahren zur herstellung einer antitumor wirksamen substanz mit immunostimulierender wirkung.
DE3716669A1 (de) Verfahren zur herstellung von zellwandkomponenten aus archaebakterien und deren verwendung als arzneimittel
DE3323093C2 (de) Pharmazeutisches Präparat zur Bekämpfung von Tumoren
DE2727236C3 (de) Verfahren zum Herstellen von Lösungen filtrierter Lysate und darauf basierendes, oral applizierbares Arzneimittel zum Vorbeugen gegen und Bekämpfen von Zahnkaries und Paradentoseerkrankungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8125 Change of the main classification

Ipc: C07H 21/02

D2 Grant after examination
8364 No opposition during term of opposition